QQ客服 官方微博 反馈留言

	Neoadjuvant Chemoradiotherapy Followed by Surgery Versus Surgery Alone for Locally Advanced Squamous Cell Carcinoma of the Esophagus (NEOCRTEC5010): A Phase III Multicenter, Randomized, Open-Label Clinical Trial
	Yang, Hong; Liu, Hui; Chen, Yuping; Zhu, Chengchu; Fang, Wentao; Yu, Zhentao; Mao, Weimin; Xiang, Jiaqing; Han, Yongtao; Chen, Zhijian
刊名	JOURNAL OF CLINICAL ONCOLOGY
	2018
卷号	36期号:27
ISSN号	0732-183X
URL标识	查看原文
语种	英语
内容类型	期刊论文
URI标识	http://www.corc.org.cn/handle/1471x/3605203
专题	复旦大学上海医学院
推荐引用方式 GB/T 7714	Yang, Hong,Liu, Hui,Chen, Yuping,et al. Neoadjuvant Chemoradiotherapy Followed by Surgery Versus Surgery Alone for Locally Advanced Squamous Cell Carcinoma of the Esophagus (NEOCRTEC5010): A Phase III Multicenter, Randomized, Open-Label Clinical Trial[J]. JOURNAL OF CLINICAL ONCOLOGY,2018,36(27).
APA	Yang, Hong.,Liu, Hui.,Chen, Yuping.,Zhu, Chengchu.,Fang, Wentao.,...&Fu, Jianhua.(2018).Neoadjuvant Chemoradiotherapy Followed by Surgery Versus Surgery Alone for Locally Advanced Squamous Cell Carcinoma of the Esophagus (NEOCRTEC5010): A Phase III Multicenter, Randomized, Open-Label Clinical Trial.JOURNAL OF CLINICAL ONCOLOGY,36(27).
MLA	Yang, Hong,et al."Neoadjuvant Chemoradiotherapy Followed by Surgery Versus Surgery Alone for Locally Advanced Squamous Cell Carcinoma of the Esophagus (NEOCRTEC5010): A Phase III Multicenter, Randomized, Open-Label Clinical Trial".JOURNAL OF CLINICAL ONCOLOGY 36.27(2018).

个性服务

查看访问统计

相关权益政策

暂无数据

收藏/分享

除非特别说明，本系统中所有内容都受版权保护，并保留所有权利。